Science Explorer Back to mapMap
Topic · Pharmacology

Drug-Induced Hepatotoxicity and Protection

Drug-Induced Hepatotoxicity and Protection is a research topic within Pharmacology. Science Explorer counts 36k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the mechanisms, risk factors, biomarkers, and management of drug-induced hepatotoxicity, with a specific emphasis on acetaminophen-induced liver injury. It covers topics such as oxidative stress, mitochondrial dysfunction, HLA genotype associations, idiosyncratic reactions, and the role of liver transplantation in severe cases.

  • Hepatotoxicity
  • Drug-Induced Liver Injury
  • Acetaminophen
  • Oxidative Stress
  • Mitochondrial Dysfunction
  • Antioxidants
  • HLA Genotype
  • Idiosyncratic Reactions
  • Biomarkers
  • Liver Transplantation
Research works
36k
fractional, since 1950
In the world top 10%
3.6k
per year above
Top-10% rate
10.1%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+8%
the tick is no change
Largest producer
China
27% of the 10 largest, 2022-now
Drug-Induced Hepatotoxicity and Protection

Which countries lead Drug-Induced Hepatotoxicity and Protection research?

By volume, China and India publish the most (1.2k and 1.1k works in 2022-now).

By volume, 2022-now

  1. 1 China 1.2k works
  2. 2 India 1.1k works
  3. 3 United States 824 works
  4. 4 Egypt 307 works
  5. 5 Nigeria 280 works
  6. 6 Türkiye 187 works
  7. 7 Iran 180 works
  8. 8 Japan 173 works
  9. 9 Indonesia 150 works
  10. 10 Pakistan 147 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

China: 26.5%India: 24.7%United States: 17.9%Egypt: 6.7%6 others listed: 24.2%27%largest
China1,222 · 26.5%India1,138 · 24.7%United States824 · 17.9%Egypt307 · 6.7%6 others listed1,117 · 24.2%

Shares of the rows listed above, not of the whole node.

Which institutions lead Drug-Induced Hepatotoxicity and Protection research?

By volume in 2022-now, Desh Bhagat Ayurvedic College and Hospital publishes the most Drug-Induced Hepatotoxicity and Protection research, followed by Cairo University and King Saud University.

Who are the leading researchers in Drug-Induced Hepatotoxicity and Protection?

The most-cited researchers publishing on Drug-Induced Hepatotoxicity and Protection include Zhong Lin Wang, Walter Churchill Willett and Mark J. Daly.

  1. 1 Zhong Lin Wang United States 491k citations
  2. 2 Walter Churchill Willett United States 411k citations
  3. 3 Mark J. Daly United States 403k citations
  4. 4 Guido Kroemer France 386k citations
  5. 5 Shizuo Akira Japan 342k citations
  6. 6 Giuseppe Remuzzi Italy 328k citations
  7. 7 Gregory Y.H. Lip United Kingdom 311k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Drug-Induced Hepatotoxicity and Protection?

The most cited paper in Drug-Induced Hepatotoxicity and Protection is "Apoptosis by Death Factor" (Shigekazu Nagata, 1997), with 5,008 citations. Next come "The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety" (3,903) and "Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis" (3,348).

Most cited papers
#PaperReleasedCitations
1 Apoptosis by Death Factor Shigekazu Nagata · Cell Open access Feb 1997 5,008
2 The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety Martins Ekor · Frontiers in Pharmacology Open access 2014 3,903
3 Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis Arun Jayant Sanyal, Naga Chalasani, Kris V. Kowdley et al. · New England Journal of Medicine Open access 28 Apr 2010 3,348
4 Bromobenzene-Induced Liver Necrosis. Protective Role of Glutathione and Evidence for 3,4-Bromobenzene Oxide as the Hepatotoxic Metabolite David J. Jollow, John R.D. Mitchell, NICOLA G. ZAMPAGLIONE et al. · Pharmacology 28 May 2008 3,308
5 Adverse drug reactions: definitions, diagnosis, and management Ivor Ralph Edwards, Jeffrey K Aronson · The Lancet Oct 2000 3,019
All 99 most cited papers, with filters and sorting

Where is Drug-Induced Hepatotoxicity and Protection research done?

The largest centres of Drug-Induced Hepatotoxicity and Protection research in 2022-now are Beijing (China), Shanghai (China), New Delhi (India) and Cairo (Egypt). Among places with at least 20 works in it, it is an unusually large share of all research in Amloh, Malappuram and Nanded.

Largest cities, 2022-now

  1. 1 BeijingChina 151 works
  2. 2 ShanghaiChina 95 works
  3. 3 New DelhiIndia 89 works
  4. 4 CairoEgypt 74 works
  5. 5 GuangzhouChina 74 works
  6. 6 ChennaiIndia 70 works
  7. 7 GizaEgypt 59 works
  8. 8 TehranIran 53 works
  9. 9 NanjingChina 53 works
  10. 10 RiyadhSaudi Arabia 52 works

Where it is the local speciality

  1. AmlohIN · 37.1 works64×
  2. MalappuramIN · 29.8 works32×
  3. NandedIN · 28.0 works25×
  4. Port HarcourtNG · 32.1 works12×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Drug-Induced Hepatotoxicity and Protection than the world average.

See Drug-Induced Hepatotoxicity and Protection on the map

Where is the best place to study Drug-Induced Hepatotoxicity and Protection?

Among universities, judged by research, Chengdu University of Traditional Chinese Medicine, King Saud University and Mansoura University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 23%fractional works in this field (log) →share of work in the world top 10% →Chengdu University o…Shanghai University …Mansoura UniversityKing Saud University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Chengdu University of Traditional Chinese MedicineChina 78.833.8%12.2×18 +106.1%
2King Saud UniversitySaudi Arabia 73.115.2%5.2×29 +20.0%
3Mansoura UniversityEgypt 68.219.5%10.3×27 +4.9%
4Shanghai University of Traditional Chinese MedicineChina 67.527.2%16.0×25 -5.3%
5Cairo UniversityEgypt 65.315.6%6.7×30 +1.6%
6Shanghai Jiao Tong UniversityChina 64.323.3%1.5×25 +18.6%
7Central South UniversityChina 62.330.1%1.6×18 +58.1%
8Tanta UniversityEgypt 57.717.7%9.6×18 +10.4%
9Sun Yat-sen UniversityChina 57.025.1%1.4×17 +18.6%
10Taif UniversitySaudi Arabia 56.022.5%6.5×8 +60.0%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Drug-Induced Hepatotoxicity and Protection, country by country

Is Drug-Induced Hepatotoxicity and Protection research growing?

Output in 2022-2025 was 8% higher than in 2018-2021, peaking in 2022. The fastest-growing topics are Drug-Induced Hepatotoxicity and Protection.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Drug-Induced Hepatotoxicity and Protection as a percentage of every work published that year, 0.027% in 2024.

still counting0.025%0.050%0.075%Drug-Induced Hepatotoxicity and Protection0.026% in 202519801990200020102020

Fractional works of Drug-Induced Hepatotoxicity and Protection over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Drug-Induced Hepatotoxicity and Protection10.3% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Drug-Induced Hepatotoxicity and Protection. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.